[1] Phelps ME.Positron emission tomography provides molecular imaging of biological processes[J].Proc Natl Acad Sci USA, 2000, 97(16):9226-9233.
[2] Phelps ME.PET:The merging of biology and imaging into molecular imaging[J].J Nucl Med, 2000, 41(4):661681.
[3] Gambhir SS, Barrio JR, Herschman HR, et al.Assay for noninvasive imaging of reporter gene expression[J].Nucl Med Biol, 1999, 26(5):481-490.
[4] Gambhir SS, Barrio JR, Herschman HR, et al.Imaging gene expression:principles and assays[J].J Nucl Cardiol, 1999, 6(2):219-233.
[5] Hnatowich DJ.Antisense and nuclear medicine[J].J Nucl Med, 1999, 40(4):693-703.
[6] Dewanjee MK, Ghafouripour AK, Kapadvanjwala M, et al.Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumour-bearing mouse model[J].J Nucl Med, 1994, 35:1054-1063.
[7] Kobori N, Imahori Y, Mineura K, et al.Visualization of mRNA expression in CNS using 11C-labeled phosphorothioate oligodeoxynucleotide[J].Neuroreport, 1999, 10(14):2971-2974.
[8] Pan D, Gambhir SS, Toyokuni T, et al.Rapid synthesis of a 5'-fluorinated oligodeoxynucleotide a model antisense probe for use in imaging with positron emission tomography (PET)[J].Bioorg Med Chem Lett, 1998, 8:1317-1320.
[9] Tavitian B, Terrazzino S, Kuhnast B, et al.In vivo imaging of oligonucleotides with positron emission tomography[J].Nature Med, 1998, 4:467-471.
[10] MacLaren DC, Toyokuni T, Cherry SR, et al.PET imaging of transgene expression[J].Biol Psychiatry, 2000, 48(5):337-348.
[11] Gambhir SS, Herschman HR, Cherry SR, et al.Imaging transgene expression with radionuclide imaging technologies[J].Neoplasia, 2000, 21(1-2).118-138.
[12] Herschman HR, MacLaren DC, Iyer M, et al.Seeing is believing:non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission to mography[J].J Neurosci Res, 2000, 59(6):699-705.
[13] Maclaren DC, Gambhir SS, Satyamurthy N, et al.Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals[J].Gene Ther, 1999, 6:785-791.
[14] Maclaren DC, Gambhir SS, Cherry SR, et al.Repetitive and non-invasive in vivo imaging of reporter gene expression using adenovirus delivered dopamine D2 receptor as a reporter gene and FESP as a PET reporter probe[J].J Nucl Med, 1998, 39:35P.
[15] Tjuvajev JG, Avril N, Oku T, et al.Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography[J].Cancer Res, 1998, 58:4333-4341.
[16] de Vries EFJ, van Waarde A, Harmsen MC, et al.11C-FMAU and 18F-FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections[J].Nucl Med Biol, 2000, 27(2):113-119.
[17] Hospers GAP, Calogero A, van Waarde A, et al.Monitoring of herpes simplex virus thymidine kinase enzynie activity using positron emission tomography[J].Cancer Res, 2000, 60:1488-1491.
[18] Alauddin MM, Conti PS.Synthesis and preliminary evaluation of 9-(4-1818F-FHBG):A new potential imaging agent for viral infection and gene therapy using PET[J].Nucl Med Biol, 1998, 25, 175-180.
[19] Yu Y, Annala AJ, Barrio JR, et al.Quantification of target gene expression by imaging reporter gene expression in living animals[J].Nature, Med, 2000, 6(8):933-937.
[20] Wunderbaldinger P, Bogdanov A, Weissleder R.New approaches for imaging in gene therapy[J].Eur J Radiol, 2000, 34(3):156-165.
[21] Gambhir SS, Barrio JR, Phelps ME, et al.Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography[J].Proc Natl Acad Sci USA, 1999, 96:2333-2338.